Bone disease after renal transplantation

Nephrology Dialysis Transplantation

Volumn 18, Issue 5, 2003, Pages 874-877

  Sperschneider, Heide ^a   Stein, Günter ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

2 microglobulin amyloidosis; Bone disease; Hyperparathyroidism; Osteoporosis; Renal transplantation

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; AZATHIOPRINE; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCINEURIN INHIBITOR; CALCITONIN; CALCITRIOL; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ESTROGEN DERIVATIVE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MAGNESIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHATE; PREDNISONE; RAPAMYCIN; RECOMBINANT HORMONE; RECOMBINANT PARATHYROID HORMONE; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

AMYLOIDOSIS; ARTICLE; BONE DISEASE; BONE NECROSIS; BONE PAIN; FEMUR HEAD NECROSIS; GRAFT REJECTION; HORMONE SUBSTITUTION; HUMAN; HYPERCALCEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATASIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KINESIOTHERAPY; METABOLIC BONE DISEASE; MINERAL METABOLISM; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; VITAMIN SUPPLEMENTATION;

AMYLOIDOSIS; BETA 2-MICROGLOBULIN; BONE DISEASES; BONE REMODELING; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY TRANSPLANTATION; OSTEONECROSIS; OSTEOPOROSIS; PAIN;

EID: 0038025736     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg029     Document Type: Article

References (36)

1. Goodmann GR, Dissamayake JR, Sodam BR et al. Immunosuppressant use without bone loss-implications for bone loss after transplantation. J Bone Miner Res 2001; 16: 72-78
2. Evenepoel P, Kuypers D, Maes B, Messiaen T, Vanrenterghem Y. Persistent hyperparathyroidism requiring parathyroidectomy after successful kidney transplantation. In 10. ESOT-Congress, 5-11 October, 2001, Lissabon, Abstract
3. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 2002; 13: 551-558
4. Drüeke TB. Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol 2000; 11: 1141-1152
5. Traindl O, Längle F, Reading S et al. Secondary hyperparathyroidism and acute tubular necrosis following renal transplantation. Nephrol Dial Transplant 1993; 8: 173-176
6. Reinhardt W, Bartelworth H, Jockenhövel F et al. Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 1998; 13: 436-442
7. Carlini RG, Rojas E, Arminio A, Weisinger JR, Bellorin-Font E. What are the bone lesions in patients with more than four years of a functioning renal transplant? Nephrol Dial Transplant 1998; 13: 103-104
8. Briner VA, Thiel G, Monier-Faugere MC et al. Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation. Transplantation 1995; 59: 1393-1400
9. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 2000; 11: 1093-1099
10. Weisinger JR, Carlinini RG, Rojas E, Bellorin-Font G. Bone disease after renal transplantation. Transplant Proc 1999; 31: 3033-3034
11. Velasques-Forero F, Mondragón A, Herrero B, Pena JC. Adynamic bone lesion in renal transplant recipients with normal renal function. Nephrol Dial Transplant 1996; 11: 58-64
12. Drüeke TB. The place of calcium and calcimimetics in the treatment of secondary hyperparathyroidism. Nephrol Dial Transplant 2001; 16 [Suppl 6]: 15-17
13. Levi M. Post-transplant hypophosphatemia. Kidney Int 2001; 59: 2377-2387
14. Felsenfeld AJ, Gutman RA, Drezner M, Llach F. Hypophosphatemia in long-term renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol. Miner Electrolyte Metab 1986; 12: 333-341
15. Caravaca F, Fernández MA, Ruiz-Calero R et al. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients. Nephrol Dial Transplant 1998; 13: 2605-2611
16. Pichette V, Bonnardeaux A, Prudhomme L, Gagné M, Cardinal J, Quimet D. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 1996; 28: 105-114
17. Grotz W, Rump LC, Niessen A et al. Treatment of osteopenia and osteoporosis after kidney tranplantation. Transplantation 1998; 66: 1004-1008
18. Cayco AV, Wysolmerski JJ, Simpson C et al. Posttransplant bone disease: evidence for a high bone resorption state. Transplantation 2000; 70: 1722-1728
19. Giannini S, D'Angelo A, Carraro G et al. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation. Clin Nephrol 2001; 353-363
20. Gruz DN, Wysolmerski JJ, Brickel HM et al. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study. Transplantation 2001; 72: 83-88
21. Keller T, Lehmann G, Sperschneider H, Stein G. Ibandronat steigert die Knochenmineraldichte bei Osteoporose nach Nierentransplantation. Med Klin (Abstr) 2002; 97: 143
22. Patel S, Kwan JTC, Mc Closkey E et al. Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 2001; 16: 1863-1870
23. Weber TJ, Quarles LD. Preventing bone loss after renal transplantation with bisphosphonates: we can... but should we. Kidney Int 2000; 57: 735-737
24. Torres A, Machado M, Concepción T et al. Influence of vitamin D receptor genotype on bone mass changes after renal transplantation. Kidney Int 1996; 50: 1726-1733
25. Fan SLS, Almond MK, Ball E, Evans K, Cunningham J. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 2000; 57: 684-690
26. Grotz W, Nagel C, Poeschel D et al. Effect of ibrandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 2001; 12: 1530-1537
27. Grotz W, Rump JA, Niessen A, Schmidt-Gayk H, Schollmeyer P. Treatment of bone pain after kidney transplantation. Transplant Proc 1998; 30: 2114-2116
28. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-1441
29. Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. J Clin Invest 1998; 102: 1627-1633
30. Grotz WH, Breitenfeldt MK, Braune SW et al. Calcineurin-inhibitor induced pain syndrome (CIPS): a severe disabling complication after organ transplantation. Transplant Int 2001; 14: 16-23
31. Tuncay IC, Demirag A, Haberal M. Muscoskeletal problems after kidney transplantation. Transplant Proc 1995; 27: 2581-2582
32. Barbosa LM, Gauthier VJ, Davis CL. Bone pain that responds to calcium channel blockers. Transplantation 1995; 59: 541-544
33. Stevens JM, Hilson AJW, Sweny P. Post-renal transplant distal limb bone pain. Transplantation 1995; 60: 305-307
34. Neubauer E, Neubauer N, Ritz E, Dreikorn K, Krause KH. Bone mineral content after renal transplantation. Klin Wochenschr 1984; 62: 93-96
35. Tang S, Chan TM, Lui SL, Li FK, Lo WK, Lai KN. Risk factors for avascular bone necrosis after renal transplantation. Transplant Proc 2000; 32: 1873-1875
36. Bardin T, Le Bail-Darné JL, Zingraff J et al. Dialysis arthropathy outcome after renal transplantation. Am J Med 1995; 99: 243-248